Pacific Biosciences of California PACB Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Pacific Biosciences of California in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pacific Biosciences of California's accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pacific Biosciences of California's accumulated depreciation?
- Pacific Biosciences of California (PACB) reported accumulated depreciation of $407.44M in Q1 2026.
- How has Pacific Biosciences of California's accumulated depreciation changed year-over-year?
- Pacific Biosciences of California's accumulated depreciation increased by 1.0% year-over-year, from $403.36M to $407.44M.
- What is the long-term trend for Pacific Biosciences of California's accumulated depreciation?
- Over 5 years (2020 to 2025), Pacific Biosciences of California's accumulated depreciation has grown at a 52.1% compound annual growth rate (CAGR), from $49.89M to $406.42M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.